Ventyx Rises on Eli Lilly Talks, Mobileye, Strategy Rises | Stock Movers

On this episode of Stock Movers:

- Eli Lilly (LLY) is in advanced talks to acquire Ventyx Biosciences (VTYX) for more than $1 billion to expand its work in immunology, according to a report in the Wall Street Journal.Ventyx shares rose 60% at 4:38 p.m. in US postmarket trading to $16.13. At that price, the San Diego-based biotech that specializes in drugs for inflammatory diseases like Crohn’s and rheumatoid arthritis is set to add $433.9 million to its market capitalization.

- Self-driving car systems company Mobileye Global (MBLY) is acquiring Israeli startup Mentee Robotics in a cash-and-stock deal valued at $900 million, as it looks to develop humanoid robots. The deal comprises $612 million in cash and as many as 26,229,714 shares of Mobileye Class A common stock, according to the company. It is expected to close in the first quarter of 2026.

- In a statement Tuesday, MSCI said it would maintain current index treatment for so-called digital asset treasury companies, including those where crypto holdings exceed 50% of total assets. That means Strategy — which holds over $60 billion in Bitcoin — will remain in the firm’s global benchmarks for now. Instead, MSCI will launch a “broader consultation” on how non-operating companies should be treated. Shares of Strategy rose around 5% in after-market trading. The stock had slumped almost 60% in the past year.

See omnystudio.com/listener () for privacy information.

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.

Check out more episodes of Stock Movers

Follow Bloomberg Podcasts on Twitter

Visit our other YouTube channels:

Bloomberg Television

Bloomberg Originals

For coverage on news, markets and more

#Stocks #Markets #Finance #Investing #Podcast #Bloomberg

Ventyx Rises on Eli Lilly Talks, Mobileye, Strategy Rises